Home       Resources      Site Map      Contact Us  
Drug Development Guide  Regulatory  Other Resources  Outsourcing Services  Consultants
Regulatory
 FDA Guidance Docs
 Warning Letters
 CGMP/GLP/GCP
 Advisory Committees
 Federal Register
 Regs, Laws & Forms
 Scale Up & Post Approval  Changes
 Drug Master Files
 Drug Approvals
 Electronic Orange Book
 Patent Extension
 Stability Protocols
 International Sites
 US directories
 Standard Operating  Procedures
Current Good Manufacturing Practice Issues on Human Use Pharmaceuticals

HUMAN DRUG CGMP NOTES is a periodic memo for FDA personnel on Current Good Manufacturing Practice Issues on Human Use Pharmaceuticals, issued by the Division of Manufacturing and Product Quality, HFD-320, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 7520 Standish Place, Rockville, MD 20855.

Human Drug CGMP Notes -2000

September 2000

June 2000

March 2000

Human Drug CGMP Notes -1999

September 1999

June 1999

March 1999

Human Drug CGMP Notes - 1998

December 1998

September 1998

June 1998

March 1998

Human Drug CGMP Notes -1997

December 1997

September 1997

June 1997

March 1997

Human Drug CGMP Notes -1996

December 1996

September 1996

June 1996

March 1996

Human Drug CGMP Notes -1995

December 1995

September 1995

June 1995

March 1995


Copyright © 1999-2004 PharmQuest Corporation. All rights reserved.
| Copyright Policy | | Disclaimer | | Privacy Policy |
Best viewed using 4.x or higher browsers from Netscape and Microsoft